|
| 37408511 | Development of an economical method to synthesize O-(2-[<sup>18</sup> F]fluoroethyl)-L-tyrosine (<sup>18</sup> FFET). | J Labelled Comp Radiopharm | 2023 |
| 37705592 | Preclinical and Clinical Use of Indigenously Developed <sup>99m</sup>Tc-Diethylenetriaminepentaacetic Acid-Bis-Methionine: l-Type Amino Acid Transporter 1-Targeted Single Photon Emission Computed Tomography Radiotracer for Glioma Management. | ACS Pharmacol Transl Sci | 2023 |
| 37456178 | Evaluation of the Diagnostic Performance of F18-Fluorodeoxyglucose-Positron Emission Tomography, Dynamic Susceptibility Contrast Perfusion, and Apparent Diffusion Coefficient in Differentiation between Recurrence of a High-grade Glioma and Radiation Necrosis. | Indian J Nucl Med | 2023 |
| 33511934 | Automated Radiosynthesis and Molecular Docking Studies of Coumarin- Triazole Hybrid with fluorine-18: A feasibility study. | Curr Radiopharm | 2022 |
| 36569507 | Female sexual function in bladder cancer: A review of the evidence. | BJUI Compass | 2022 |
| 36452501 | Diffusion-weighted MRI to determine response and long-term clinical outcomes in muscle-invasive bladder cancer following neoadjuvant chemotherapy. | Front Oncol | 2022 |
| 36329151 | Synthesis, characterization, and radiosynthesis of fluorine-18-AVT-011 as a Pgp chemoresistance imaging marker. | Sci Rep | 2022 |
| 33153893 | Radiosynthesis challenges of <sup>11</sup>C and <sup>18</sup>F-labeled radiotracers in the FX2C/N tracerlab and their validation through PET-MR imaging. | Appl Radiat Isot | 2021 |
| 35475135 | Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators. | BJUI Compass | 2021 |
| 33499603 | Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology. | J Med Chem | 2021 |
| 34630267 | Can High b Value Diffusion Be a Surrogate Marker for PET-A MR/PET Study in Neurooncology Set Up. | Front Neurol | 2021 |
| 34295760 | Endoscopic surveillance for bladder cancer: a systematic review of contemporary worldwide practices. | Transl Androl Urol | 2021 |
| 30559065 | Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes. | Eur Urol Focus | 2020 |
| 31877537 | Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis. | Eur J Med Chem | 2020 |
| 31668714 | A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients. | Eur Urol Oncol | 2020 |
| 32106038 | Synthesis, <sup>18</sup>F-radiolabeling and apoptosis inducing studies of novel 4, 7-disubstituted coumarins. | Bioorg Chem | 2020 |
| 32738568 | Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis, <sup>18</sup>F-radiolabeling & galectin-1 inhibition studies. | Bioorg Chem | 2020 |
| 32851811 | A mediation analysis to explain socio-economic differences in bladder cancer survival. | Cancer Med | 2020 |
| 32386492 | Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents. | Mini Rev Med Chem | 2020 |
| 32493286 | Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence. | BMC Urol | 2020 |
| 30652213 | A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy. | World J Urol | 2019 |
| 29802552 | Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics. | Mol Imaging Biol | 2019 |
| 31174452 | Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival. | Scand J Urol | 2019 |
| 29662167 | Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. | Nat Genet | 2018 |
| 30187529 | Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients. | Int J Urol | 2018 |
| 28577428 | VPAC1 Targeted <sup>64</sup>Cu-TP3805 kit preparation and its evaluation. | Nucl Med Biol | 2017 |
| 28233731 | Ex vivo study of prostate cancer localization using rolling mechanical imaging towards minimally invasive surgery. | Med Eng Phys | 2017 |
| 28945760 | Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. | PLoS Genet | 2017 |
| 28571827 | Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital. | Clin Genitourin Cancer | 2017 |
| 27026308 | Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (⿤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer. | Int J Radiat Oncol Biol Phys | 2016 |
| 26519886 | VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man. | Urology | 2016 |
| 27151655 | The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer. | Oncologist | 2016 |
| 27237136 | Radiosynthesis of [18F]-fluorobenzoate-doxorubicin Using Acylation Approach. | Curr Radiopharm | 2016 |
| 27228294 | Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder. | Br J Cancer | 2016 |
| 26844850 | Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents. | Cancer Biother Radiopharm | 2016 |
| 25730763 | Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. | Nat Genet | 2015 |
| 26524969 | Molecular aspects of metal oxide nanoparticle (MO-NPs) mediated pharmacological effects. | Life Sci | 2015 |
| 26232562 | Radiolabeling optimization and characterization of (68)Ga labeled DOTA-polyamido-amine dendrimer conjugate - Animal biodistribution and PET imaging results. | Appl Radiat Isot | 2015 |
| 25897675 | Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder. | Br J Cancer | 2015 |
| 25968484 | Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results. | J Labelled Comp Radiopharm | 2015 |
| 26018901 | Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. | Nat Genet | 2015 |
| 25702887 | Preclinical evaluation of (99m)Tc labeled gefitinib as a potential scintigraphic probe for the detection of tumors expressing epidermal growth factor receptors. | Appl Radiat Isot | 2015 |
| 24960151 | Role of neuroimaging in drug development. | Rev Neurosci | 2014 |
| 23317733 | The addition of the surgical robot to skin cancer management. | Ann R Coll Surg Engl | 2013 |
| 22035251 | Urology training: past, present and future. | BJU Int | 2012 |
| 22433470 | Standard versus tubeless percutaneous nephrolithotomy: a systematic review. | Urol Int | 2012 |
| 22432523 | Preclinical evaluation of [99m]Tc-labeled doxorubicin as a potential scintigraphic probe for tumor imaging. | Cancer Biother Radiopharm | 2012 |
| 21276175 | Reducing the time to continence after radical prostatectomy. | BJU Int | 2011 |
| 21884906 | Editorial comment. | Urology | 2011 |
| 21959706 | Robot assisted laparoscopic prostatectomy. Striving for Trifecta outcomes in localised prostate cancer. | Minerva Med | 2011 |